中文名称 |
英文名称 |
CAS号 |
化学式 |
结构式图片 |
—— |
Ru<sub>2</sub>(OAc)<sub>4</sub>Cl |
—— |
C8H12Cl2O8Ru2 |
|
—— |
(R)-α-(furan-2-yl)-α-hydroxyacetic acid |
—— |
C6H6O4 |
|
—— |
(R)-methyl 2-acetamido-7-chloroheptanoate |
—— |
C16H18N2O5 |
|
—— |
(R)-Nortrimebutine |
—— |
C21H27NO5 |
|
—— |
rac-(2S,3R,4R)-1-acetyl-N-(2-hydroxyethyl)-2,3-dimethyl-4-((6-methylpyridin-2-yl)amino)-1,2,3,4-tetrahydroquinoline-6-carboxamide |
—— |
C22H28N4O3 |
|
—— |
(R)-3-hydroxybutyrylcarnitine |
875668-57-8 |
C11H21NO5 |
|
—— |
(R)-3-hydroxybutyryl carnitine |
—— |
C11H21NO5 |
|
—— |
(R)-N-(4-chlorophenyl)-2-((1S,4S)-4-(6-fluoroquinolin-4-yl)cyclohexyl)propanamide |
1923833-60-6 |
C24H24ClFN2O |
|
—— |
(R)-carnitine mesylate mesylate |
—— |
CH3O3S*C8H18NO5S |
|
—— |
R-carnitine isobutyl ester |
—— |
C11H24NO3*Cl |
|
—— |
(R)-3,4-epoxy-3-methyl-1-butanol |
—— |
C5H10O2 |
|
—— |
rac-(2S,3R,4R)-1-acetyl-2-ethyl-N-(2-hydroxyethyl)-3-methyl-4-((6-methylpyridin2-yl)amino)-1,2,3,4-tetrahydroquinoline-6-carboxamide |
—— |
C23H30N4O3 |
|
—— |
(RS)-5-chloro-2-(4-chlorophenyl)-3-(3-chloro-2-fluoropropyl)-1H-indole |
—— |
C17H13Cl3FN |
|
—— |
(RS)-1-{3-[5-Chloro-2-(4-Chlorophenyl)-1-Methyl-1H-Indol-3-yl]-2-Fluoropropyl}-4-(Phenylmethyl)-4-Piperidinol |
—— |
C30H31Cl2FN2O |
|
—— |
(R)-N-Hydroxy-N-[2-((3-phenoxybenzoyl)amino)propyl]urea |
—— |
C17H19N3O4 |
|
—— |
rac-4-[6-chloro-3-(3-chloro-benzyl)-2-oxo-2,3-dihydro-1H-indol-3-yl]-piperidine-1-carboxylic acid methylamide |
—— |
C22H23Cl2N3O2 |
|
—— |
(R)-cilnidipine |
—— |
C27H28N2O7 |
|
—— |
(Rp)/(Sp)-menthyl (hydroxymethyl)-H-phosphinate |
—— |
C11H23O3P |
|
—— |
(R<sub>p</sub>)-menthyl (hydroxymethyl)-H-phosphinate |
—— |
C11H23O3P |
|
—— |
(R)-2-fluoro-5-(1-(3-fluoro-5-(trifluoromethyl)phenyl)-2-phenyl-1-(3-(trifluoromethyl)benzamido)ethyl)phenyl methylcarbamate |
—— |
C31H22F8N2O3 |
|
—— |
(R)-N-(1-(4-fluoro-3-hydroxyphenyl)-1-(3-fluoro-5-(trifluoromethyl)phenyl)-2-phenylethyl)-3-(trifluoromethyl)benzamide |
—— |
C29H19F8NO2 |
|
—— |
reduced laminaraheptaose |
—— |
C42H72O36 |
|
—— |
(R,S′)-(+)-5-(1-hydroxy-2-((1-(4-methoxyphenyl)butan-2-yl)amino)ethyl)benzene-1,3-diol |
—— |
C19H25NO4 |
|
—— |
(R)-(-)-5-(1-hydroxy-2-((4-methoxyphenethyl)amino)ethyl)benzene-1,3-diol |
—— |
C17H21NO4 |
|
—— |
(R,R′)-5-(1-hydroxy-2-((1-(4-methoxyphenyl)-3-methylbutan-2-yl)amino)ethyl)-benzene-1,3-diol |
—— |
C20H27NO4 |
|
—— |
(R,R')-(-)-5-(1-hydroxy-2-((1-(4-methoxyphenyl)butan-2-yl)amino)ethyl)benzene-1,3-diol |
—— |
C19H25NO4 |
|
—— |
(R,R′)-5-(1-hydroxy-2-((1-(4-methoxyphenyl)pentan-2-yl)amino)ethyl)benzene-1,3-diol |
—— |
C20H27NO4 |
|
—— |
(R,S′)-5-(1-hydroxy-2-((1-(4-methoxyphenyl)pentan-2-yl)amino)ethyl)benzene-1,3-diol |
1531622-36-2 |
C20H27NO4 |
|
—— |
(R)-northioridazine |
—— |
C20H24N2S2 |
|
—— |
[Rh2(η(5)-C5H5)2(μ-CO)(μ-η(2)-CF3CCCF3)] |
—— |
C15H10F6ORh2 |
|
—— |
<R-(S*,R*)>-α-<1-<(1-phenyl-6-propoxy-1H-pyrazolo<3,4-d>pyrimidin-4-yl)amino>ethyl>benzenemethanol |
—— |
C23H25N5O2 |
|
—— |
(R)-3-[N'-(5-acetyl-2H-pyrazole-3-carbonyl)-N-(5'-chloro-2'-fluorobiphenyl-4-ylmethyl)hydrazino]-2-hydroxypropionic acid |
—— |
C22H20ClFN4O5 |
|
—— |
(R)-2-(benzo[1,3]dioxol-5-yl)-6-isopropoxy-4-methoxy-2H-chromene-3-carboxylic acid (1S,2R)-(+)-norephedrine salt |
—— |
C9H13NO*C21H20O7 |
|
—— |
(R)-3'-chlorophenylbromomethylcarbinol |
—— |
C8H8BrClO |
|
—— |
rac-(3R,3aS)-3-(4-chlorophenyl)-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-2-carbothioamide |
—— |
C18H16ClN3S |
|
—— |
(RS,SR)-α-[1-[[(pyridin-3-yl)methyl]amino]ethyl]benzenemethanol |
—— |
C15H18N2O |
|
—— |
rac-(3S,3aS)-3-phenyl-3,3a,4,5-tetrahydro-2H-benzo[g]indazole-2-carbothioamide |
—— |
C18H17N3S |
|
—— |
(R)-1-(4-amino-3-chloro-5-trifluoromethyl-benzyl)-2-(4-{1-[2-(2-dimethylamino-ethoxycarbonyl)-ethyl]-piperidin-4-yl}-piperazin-1-yl)-2-oxo-ethyl 4-(2-oxo-1,2,4,5-tetrahydro-1,3-benzodiazepin-3-yl)-piperidine-1-carboxylate |
—— |
C41H56ClF3N8O6 |
|
—— |
(R)-N-Acetyl-S-<(5S,6S)-2-carboxy-5,6-dihydro-5-hydroxy-6-naphthyl>cysteine |
—— |
C16H17NO6S |
|
—— |
(R)-N-Acetyl-S-<(5R,6R)-2-carboxy-5,6-dihydro-5-hydroxy-6-naphthyl>cysteine |
—— |
C16H17NO6S |
|
—— |
(R)-N-Acetyl-S-<(7S,8S)-2-carboxy-7,8-dihydro-8-hydroxy-7-naphthyl>cysteine |
—— |
C16H17NO6S |
|
—— |
(R)-N-Acetyl-S-<(7R,8R)-2-carboxy-7,8-dihydro-8-hydroxy-7-naphthyl>cysteine |
—— |
C16H17NO6S |
|
—— |
rel-(4R,5R)-4-para-methoxyphenyl-5-trifluoroacetylamino-2,2-dioxo-1,2,3-oxathiazinane |
—— |
C12H13F3N2O5S |
|
—— |
rel-(4R,5R)-2-tert-butoxycarbonylamino-4-para-methoxyphenyl-2,2-dioxo-1,2,3-oxathiazinane |
—— |
C15H22N2O6S |
|
—— |
(R)-2-acetylamino-3-(2,6-dimethylbenzoylthio)propionic acid |
—— |
C14H17NO4S |
|
—— |
R-(2-nitrophenyl)-N-acetyl-L-cysteine |
—— |
C11H12N2O5S |
|
—— |
(R)-2-acetamido-3-(((4-(diphenylphosphinyl)butyl)carbamothioyl)thio)propanoic acid |
—— |
C22H27N2O4PS2 |
|
—— |
(R)-2-acetamido-3-(((2-(diphenylphosphinyl)ethyl)carbamothioyl)thio)propanoic acid |
—— |
C20H23N2O4PS2 |
|
—— |
(R)-2-acetamido-3-(((5-(diphenylphosphinyl)pentyl)carbamothioyl)thio)propanoic acid |
—— |
C23H29N2O4PS2 |
|
—— |
racemic (1aS,6aR)-3,4-dichloro-6,6a-dihydro-1aH-1-oxa-cyclopropa[a]indene |
—— |
C9H6Cl2O |
|